QUILT-3.020: A Study of ALT-801 in Patients With Relapsed or Refractory Multiple Myeloma
Clinical trial NCT01670994 · TERMINATED
Trial details
- NCT number
- NCT01670994
- Sponsor
- Altor BioScience
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-08-14
- Primary completion
- 2015-09-09
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.